LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 56.71 | 770.25 | 2152 | 8001 | 0.2690 | 0.3556 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 56.71 | 770.25 | 2131 | 8001 | 0.2663 | 0.3517 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.94 | 770.25 | 2243 | 8444 | 0.2656 | 0.3626 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.94 | 770.25 | 2221 | 8444 | 0.2630 | 0.3587 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 61.16 | 770.25 | 2281 | 8892 | 0.2565 | 0.3602 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 61.16 | 770.25 | 2252 | 8892 | 0.2533 | 0.3553 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.39 | 770.25 | 2353 | 9326 | 0.2523 | 0.3640 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.39 | 770.25 | 2308 | 9326 | 0.2475 | 0.3567 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.61 | 770.25 | 2433 | 9736 | 0.2499 | 0.3692 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.61 | 770.25 | 2397 | 9736 | 0.2462 | 0.3637 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.83 | 770.25 | 2507 | 10078 | 0.2488 | 0.3745 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.83 | 770.25 | 2457 | 10078 | 0.2438 | 0.3671 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.05 | 770.25 | 2585 | 10413 | 0.2482 | 0.3803 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.05 | 770.25 | 2547 | 10413 | 0.2446 | 0.3748 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.27 | 770.25 | 2686 | 10730 | 0.2503 | 0.3891 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.27 | 770.25 | 2638 | 10730 | 0.2458 | 0.3826 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.50 | 770.25 | 2730 | 10991 | 0.2484 | 0.3909 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.50 | 770.25 | 2681 | 10991 | 0.2439 | 0.3844 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.75 | 770.25 | 2841 | 11262 | 0.2522 | 0.4011 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.75 | 770.25 | 2754 | 11262 | 0.2445 | 0.3899 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.98 | 770.25 | 2926 | 11518 | 0.2540 | 0.4078 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.98 | 770.25 | 2825 | 11518 | 0.2453 | 0.3952 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 81.20 | 770.25 | 2984 | 11766 | 0.2536 | 0.4110 | MN20160304_L02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 81.20 | 770.25 | 2923 | 11766 | 0.2484 | 0.4037 | MN20160304_L02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 83.42 | 770.25 | 3083 | 12031 | 0.2562 | 0.4187 | MN20160304_L02 | F03 |